Genpact LTD
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.1B | $4.8B | $4.5B | $4.4B | $4.0B |
| Cost of revenue | $3.2B | $3.1B | $2.9B | $2.8B | $2.6B |
| Gross profit | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B |
| Selling, general & administrative | $1.0B | $967.1M | $913.1M | $938.4M | $865.7M |
| Operating income | $750.2M | $702.1M | $630.9M | $502.2M | $509.0M |
| Interest expense | $73.5M | $79.5M | $66.3M | $58.1M | $58.3M |
| Pretax income | $730.1M | $676.8M | $602.2M | $465.2M | $483.1M |
| Income tax expense | $177.7M | $163.2M | -$29.0M | $111.8M | $113.7M |
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.4M |
| Balance Sheet | |||||
| Cash and equivalents | $853.8M | $648.2M | $583.7M | $646.8M | $899.5M |
| Current assets | $2.7B | $2.1B | $1.9B | $1.8B | $1.9B |
| Total assets | $5.8B | $5.0B | $4.8B | $4.6B | $5.0B |
| Current liabilities | $1.6B | $963.7M | $1.3B | $1.1B | $1.3B |
| Total liabilities | $3.3B | $2.6B | $2.6B | $2.8B | $3.1B |
| Stockholders' equity | $2.5B | $2.4B | $2.2B | $1.8B | $1.9B |
| Cash Flow Statement | |||||
| Cash from operations | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M |
| Depreciation and amortization | $70.7M | $69.8M | $72.5M | $86.8M | $109.1M |
| Stock-based compensation | $89.6M | $66.4M | $88.6M | $77.4M | $82.0M |
| Capital expenditure | $78.2M | $82.8M | $55.4M | $50.6M | $53.3M |
| Free cash flow | $734.7M | $532.7M | $435.4M | $393.1M | $640.9M |
| Dividends paid | $117.7M | $108.5M | $100.0M | $91.8M | $80.5M |
| Share repurchases | $282.9M | $252.7M | $225.5M | $214.1M | $298.2M |
| Impairments | — | $0 | $0 | $29.2M | $915,000 |
Shares outstanding 169.5M · Free float 5.6%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.